Sharp Therapeutics Corp. (TSXV:SHRX)
Canada · Delayed Price · Currency is CAD 2.100
-0.050 (-2.33%)
At close: Apr 17, 2026
Sharp Therapeutics Market Cap
Sharp Therapeutics has a market cap or net worth of CAD 63.16 million as of May 1, 2026.
Market Cap
63.16M
Enterprise Value
63.61M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.10
Market Cap Chart
Since January 17, 2025, Sharp Therapeutics's market cap has increased from 62.09M to 63.16M, an increase of 1.73%. That is a compound annual growth rate of 1.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 63.16M | -15.82% |
| Dec 30, 2025 | 75.03M | 20.85% |
| Jan 17, 2025 | 62.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ME Therapeutics Holdings | 75.12M |
| Sernova Biotherapeutics | 59.65M |
| NurExone Biologic | 50.63M |
| Medicenna Therapeutics | 49.22M |
| Quantum BioPharma | 45.47M |
| Defence Therapeutics | 43.09M |
| BriaCell Therapeutics | 41.33M |
| Telescope Innovations | 39.19M |